WINDLAS logo

Windlas Biotech Limited Stock Price

NSEI:WINDLAS Community·₹17.4b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 3 Fair Values set on narratives written by author

WINDLAS Share Price Performance

₹824.30
-112.15 (-11.98%)
₹824.30
-112.15 (-11.98%)
Price ₹824.30

WINDLAS Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet second-rate dividend payer.

0 Risks
2 Rewards

Windlas Biotech Limited Key Details

₹9.0b

Revenue

₹5.6b

Cost of Revenue

₹3.5b

Gross Profit

₹2.8b

Other Expenses

₹664.6m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
31.49
38.37%
7.35%
5.1%
View Full Analysis

About WINDLAS

Founded
2001
Employees
1346
CEO
Komal Gupta
WebsiteView website
windlas.com

Windlas Biotech Limited, a contract development and manufacturing organization, manufactures and trades in pharmaceutical products in India. The company offers contract manufacturing; customized formulations; contract research and manufacturing services; customized formulation; and regulatory services. It also manufactures tablets, capsules, oral solids, modified-release formulations, chewable and dispersible tablets, customized generics, and complex generics and multi-drug combinations, as well as injectables, including liquid vials, lyophilized vials, and ampoules. In addition, the company offers generic drugs for respiratory, anti-diabetic, gastroenterology, cardiovascular and multivitamin, neuro anti-psychotic, diabetic care, nutraceuticals, nutritional supplement, urology, pain management, and injectable therapies. It also exports generic medicines, health supplements, and custom-branded formulations. Windlas Biotech Limited was incorporated in 2001 and is headquartered in Dehradun, India.

Recent WINDLAS News & Updates

Analysis Article May 13

Windlas Biotech (NSE:WINDLAS) Ticks All The Boxes When It Comes To Earnings Growth

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...

Recent updates

No updates